Crinetics Pharmaceuticals, Inc. Annual Operating Income (Loss) in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Crinetics Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2016 to 2023.
  • Crinetics Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$82.8M, a 56.2% decline year-over-year.
  • Crinetics Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$278M, a 44.8% decline year-over-year.
  • Crinetics Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$223M, a 32.6% decline from 2022.
  • Crinetics Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$168M, a 55.9% decline from 2021.
  • Crinetics Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$108M, a 43.7% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$223M -$54.7M -32.6% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 -$168M -$60.2M -55.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 -$108M -$32.7M -43.7% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 -$75M -$21.1M -39.2% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 -$53.8M -$25.1M -87.5% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-30
2018 -$28.7M -$19.6M -215% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-30
2017 -$9.13M -$3.08M -51% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-09
2016 -$6.04M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.